On November 18, 2021 Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant
On October 1, 2021 Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon
On June 25, 2021 Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy
On April 14, 2021 Accelerated phase 1a/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses
